IsoRay, Inc. produces therapeutic radioactive isotopes. It provides applications include prostate cancer; ocular melanoma; head, neck and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancer. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.
